Company intelligence / Profile preview
Tapestry Pharmaceuticals, Inc.
- Ownership
- Private
- Development stage
- Other
Overview
Tapestry Pharmaceuticals was a biopharmaceutical company developing proprietary therapies primarily targeting cancer and hereditary diseases. The company originated as NaPro BioTherapeutics before rebranding in the early/mid–2000s. Its pipeline included several small molecule drugs—mainly novel taxane derivatives designed to overcome drug resistance in solid tumors—as well as oligonucleotide-based approaches for genetic disorders. The most advanced program reached Phase II clinical trials but all development appears to have ceased; the company has been inactive ("dead") since at least the mid–2010s[2][6].
- Therapeutic areas
- OncologyRare Diseases
- Modalities
- Small molecules (notably taxanes and quassinoid analogues)Oligonucleotides
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Tapestry Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tapestry Pharmaceuticals, Inc..